215 related articles for article (PubMed ID: 23861877)
1. Rapamycin treatment improves neuron viability in an in vitro model of stroke.
Fletcher L; Evans TM; Watts LT; Jimenez DF; Digicaylioglu M
PLoS One; 2013; 8(7):e68281. PubMed ID: 23861877
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin prevents cadmium-induced neuronal cell death via targeting both mTORC1 and mTORC2 pathways.
Xu C; Liu C; Liu L; Zhang R; Zhang H; Chen S; Luo Y; Chen L; Huang S
Neuropharmacology; 2015 Oct; 97():35-45. PubMed ID: 26002629
[TBL] [Abstract][Full Text] [Related]
3. The mechanistic target of rapamycin (mTOR) pathway and S6 Kinase mediate diazoxide preconditioning in primary rat cortical neurons.
Dutta S; Rutkai I; Katakam PV; Busija DW
J Neurochem; 2015 Sep; 134(5):845-56. PubMed ID: 26016889
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage.
Völkers M; Konstandin MH; Doroudgar S; Toko H; Quijada P; Din S; Joyo A; Ornelas L; Samse K; Thuerauf DJ; Gude N; Glembotski CC; Sussman MA
Circulation; 2013 Nov; 128(19):2132-44. PubMed ID: 24008870
[TBL] [Abstract][Full Text] [Related]
5. Genetic and pharmacologic evidence that mTOR targeting outweighs mTORC1 inhibition as an antimyeloma strategy.
Chen X; Díaz-Rodríguez E; Ocio EM; Paiva B; Mortensen DS; Lopez-Girona A; Chopra R; Miguel JS; Pandiella A
Mol Cancer Ther; 2014 Feb; 13(2):504-16. PubMed ID: 24431075
[TBL] [Abstract][Full Text] [Related]
6. Computational research of mTORC1 inhibitor on cerebral ischemia-reperfusion injury.
Li H; Yang W; Wang Z; Wang X; Hao Y; Xi J; Lu H; Du Z; Feng J; Zhang B; Ma D
Aging (Albany NY); 2021 Aug; 13(15):19598-19613. PubMed ID: 34343111
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin induces of protective autophagy in vascular endothelial cells exposed to oxygen-glucose deprivation.
Urbanek T; Kuczmik W; Basta-Kaim A; Gabryel B
Brain Res; 2014 Mar; 1553():1-11. PubMed ID: 24462935
[TBL] [Abstract][Full Text] [Related]
8. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated mTORC1 represses autophagic-related mRNA translation in neurons exposed to ischemia-reperfusion injury.
Hua R; Wei H; Liu C; Shi Z; Xing Y
J Cell Biochem; 2019 Sep; 120(9):15915-15923. PubMed ID: 31081172
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis.
Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG
PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
[TBL] [Abstract][Full Text] [Related]
13. Platycodin D protects cortical neurons against oxygen-glucose deprivation/reperfusion in neonatal hypoxic-ischemic encephalopathy.
Wang G; Guo H; Wang X
J Cell Biochem; 2019 Aug; 120(8):14028-14034. PubMed ID: 30945345
[TBL] [Abstract][Full Text] [Related]
14. Propofol inhibited autophagy through Ca
Sun B; Ou H; Ren F; Huan Y; Zhong T; Gao M; Cai H
Mol Med; 2018 Nov; 24(1):58. PubMed ID: 30470173
[TBL] [Abstract][Full Text] [Related]
15. p53 inhibition provides a pivotal protective effect against ischemia-reperfusion injury in vitro via mTOR signaling.
Li X; Gu S; Ling Y; Shen C; Cao X; Xie R
Brain Res; 2015 Apr; 1605():31-8. PubMed ID: 25681550
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation.
Walker NM; Belloli EA; Stuckey L; Chan KM; Lin J; Lynch W; Chang A; Mazzoni SM; Fingar DC; Lama VN
J Biol Chem; 2016 Mar; 291(12):6262-71. PubMed ID: 26755732
[TBL] [Abstract][Full Text] [Related]
17. Nutrient signaling to mTOR and cell growth.
Jewell JL; Guan KL
Trends Biochem Sci; 2013 May; 38(5):233-42. PubMed ID: 23465396
[TBL] [Abstract][Full Text] [Related]
18. Schizandrin Protects against OGD/R-Induced Neuronal Injury by Suppressing Autophagy: Involvement of the AMPK/mTOR Pathway.
Wang G; Wang T; Zhang Y; Li F; Yu B; Kou J
Molecules; 2019 Oct; 24(19):. PubMed ID: 31597329
[TBL] [Abstract][Full Text] [Related]
19. Suppression of REDD1 attenuates oxygen glucose deprivation/reoxygenation-evoked ischemic injury in neuron by suppressing mTOR-mediated excessive autophagy.
Sun J; Yue F
J Cell Biochem; 2019 Sep; 120(9):14771-14779. PubMed ID: 31021470
[TBL] [Abstract][Full Text] [Related]
20. A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models.
Zhang H; Berel D; Wang Y; Li P; Bhowmick NA; Figlin RA; Kim HL
PLoS One; 2013; 8(1):e54918. PubMed ID: 23349989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
